Achieve life sciences announces participation at upcoming investor conferences

Seattle and vancouver, british columbia, sept. 02, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that rick stewart, ceo of achieve life sciences, will be participating at two upcoming conferences. details are as follows:
ACHV Ratings Summary
ACHV Quant Ranking